ARTICLE | Financial News
Supernus raises $75 million in note deal
April 27, 2013 12:23 AM UTC
Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) raised $75 million through the sale of 7.5% senior secured convertible notes. The notes mature on May 1, 2019, and initially convert at $5.30. Supernus prop...